FY23 NPAT swung to a $3.2m loss as below-EBITDA charges crushed thin trading

Reported revenue was essentially flat on a like-for-like basis at $6.6m (+0.7%), and group EBITDA was a modest positive $0.75m after absorbing a $0.45m credit impairment on receivables and an impairment of goodwill and intangibles relating to the Triple Two acquisition.

The damage sits below EBITDA: roughly $4.0m of depreciation, amortisation, interest and impairment charges turned a thin operating result into a $3.2m loss. Cash fell 61.5% to $0.4m, equity fell 53.9% to $1.4m, and operating cash flow worsened to -$0.5m from -$0.1m. Net debt of $2.7m equates to roughly 3.6x reported EBITDA.

• Equity has dropped to $1.4m and cash to $0.4m, while gross borrowings remain at $3.1m. ROE moved from +11.1% to -226.8%. The business has limited headroom to absorb another year of similar below-line charges without external funding.
• Underlying franchise momentum is real but is not yet sized to the cost base. Franchisee outlet sales rose 24% to NZ$53.6m, recurring group revenue rose 15% to NZ$3.8m, and the dominant UK & IRE franchising segment generated a segment result of $1.3m on $6.4m of revenue. That progress is being consumed by the New Zealand head-office segment (-$1.2m result) and by impairment and amortisation charges associated with prior acquisitions.
• Cash conversion broke down. Operating cash flow was -64.5% of EBITDA, so even the positive trading number did not translate into cash. With trade receivables flat at $1.3m and receivable days steady around 73, the cash gap reflects the loss-making operations rather than a working-capital build, which means the burn is structural until the franchise system scales further.

HY23 commentary asserted "full year revenue and profit on track to meet expectations" and reported a $0.1m interim profit; the implied second half therefore swung to roughly -$3.3m NPAT on $3.5m of revenue. That is a sharp negative deviation from the half-year tone and is the single largest investor-relevant fact in the release.

Because no forward work or guidance is disclosed, the result does not support any view on FY24 recovery. What it does support is that H2 absorbed the bulk of the impairment and amortisation hit and that the cash and equity exit positions are materially tighter than at HY23.

However, EBITDA already includes the $0.45m credit impairment on receivables, so the $0.75m EBITDA cannot be adjusted upward on that basis without double-counting management's own framing.

The durable signals are mixed. Recurring revenue mix improved to 57.5% from 50.3%, UK & IRE franchising margin moved up to 21.1% from 19.6%, and UK Retail losses narrowed. Against that, operating cash flow worsened, cash halved, and net debt to EBITDA reached 3.6x. The trading recovery is genuine, but the balance-sheet exit position is the part of the result that is hardest to reverse with another year of similar revenue.

This briefing cannot assess covenant headroom, lender support, or the company's internal FY24 budget, none of which is disclosed in the release.